FacultyFaculty/Author Profile
T. Reed Stephens

T. Reed Stephens

McDermott Will & Emery LLP

Washington, DC, USA


T. Reed Stephens, a partner in McDermott Will & Emery’s Washington, D.C. office, practices in the Firm's Health Care Advisory Practice Group. Mr. Stephens’ Litigation and Compliance Advisory practice focuses on health care systems and companies in global industries, such as the pharmaceutical industry. These clients have matters that involve sensitive, complex issues of federal and state regulatory enforcement including ICE, the Depart. of Veterans Affairs, the FDA, the Dept. of Health & Human Services, Congressional Committees, and many State Attorneys General. In his practice, he handles matters for these clients in the following areas: (1) Litigation and Government Investigations; (2) Global Regulatory Compliance including the FCPA; (3) Public Policy -- providing strategic advice to assist clients in navigating various state and federal legislative initiatives; (4) Transactional -- risk assessment and valuation of liabilities as part of the M & A process and intellectual property matters.

Mr. Stephens is a nationally recognized expert in the pharmaceutical fraud and abuse and corporate compliance areas -- speaking frequently to private industry about the federal False Claims Act, the federal and state Anti-kickback laws, the Stark Law, off label drug promotion and the development and implementation of corporate compliance programs. While working for the Department of Justice, he was lead or co-lead counsel in some 60 investigations from 1995 to 2003, the majority involving allegations of health care fraud including more than a dozen multimillion dollar recoveries for the federal government.

While in the government, Mr. Stephens worked closely with the Depart. of Health and Human Services Office of Counsel to the Inspector General to develop various corporate integrity agreements and the Inspector General's Guidance to Pharmaceutical Manufacturers. Mr. Stephens has also been an instructor at the Attorney General’s National Advocacy Center (1998, 2000, and 2002). While with the Department of Justice, Mr. Stephens earned several honors including a Civil Division Special Commendation for Outstanding Service in 2002. Nightengale’s Healthcare News named him one of its “Outstanding Litigators for 2006”, chosen by LMG Life Sciences Guide as a “2013 Life Sciences Star,” and he has been ranked since 2008 in Chambers USA in Health Care. He was recently named one of Washington’s Best Lawyers for Health Care for 2013 by the Washingtonian Magazine.

Mr. Stephens served two three year terms in various capacities on the Board of Trustees of the Norwood School in Bethesda, Maryland. After obtaining degrees from Princeton University and Stanford Law School, where he was a member of the Articles Board of The Law Review, he clerked for the Honorable Clifford Scott Green of the U.S. District Court for the Eastern District of Pennsylvania.
T. Reed Stephens is associated with the following items:
CHB Chapters  CHB Chapters The Health Care Industry and DOJ’s New Corporate Conduct Enforcement Guidelines - Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, November 02, 2016
Huge Stark Law Hospital Settlements and Physician Culpability—The New Normal Post-Tuomey? - Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, November 02, 2016
Effective Compliance Programs and Investigations (PowerPoint slides) - Life Sciences 2016: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, November 02, 2016
Effective Compliance Programs and Investigations (November 2, 2016) - Life Sciences 2017: Navigating Legal Challenges in the Drug and Device Industries, Thursday, October 05, 2017
Web Segment  Web Segment Effective Compliance Programs and Investigations: A Hypothetical - Life Sciences 2017: Navigating Legal Challenges in the Drug and Device Industries, Thursday, October 12, 2017
MP3 Audio  MP3 Audio Effective Compliance Programs and Investigations: A Hypothetical - Effective Compliance Programs and Investigations: A Hypothetical, Thursday, October 12, 2017
Transcripts  Transcripts Effective Compliance Programs and Investigations: A Hypothetical - Effective Compliance Programs and Investigations: A Hypothetical, Thursday, October 12, 2017
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Effective Compliance Programs and Investigations: A Hypothetical - Effective Compliance Programs and Investigations: A Hypothetical, Thursday, October 12, 2017
On-Demand Web Programs  On-Demand Web Programs Life Sciences 2017: Navigating Legal Challenges in the Drug and Device Industries, Wednesday, October 18, 2017, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.